AVAI News and Press, Avant Technologies Inc. From 12/08/25

Issued on behalf of Quantum Security Encryption Corp. VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) -- USANewsGroup .com Market Intelligence Brief – The market is in triage. Speculative growth multiples are collapsing. Cash-burning "disruptors" are...

VANCOUVER, British Columbia, Dec. 06, 2025 (GLOBE NEWSWIRE) -- USANewsGroup .com Market Intelligence Brief – The market is efficient... until it isn't. While the S&P 500 grinds higher on momentum, entire subsectors have been left behind, creating a massive disconnect be...

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – The metabolic disorder therapeutics market projects growth to $120.7 billion by 2030 as biotechnology firms pioneer organ-level treatments addressing diabetes, liver dise...

2025-11-18 08:45:11 ET New York, NY – October 18, 2025 – The advance anti-aging therapies market is expanding quickly fueled by a larger senior population and increased consumer focus on preventive and longevity-focused health. A report from Grand View Research said that t...

Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cellbased therapies for diabetes and age-related disorders, today announced that its 50/50 joint venture (Klothonova) with Austrianova has entered...

2025-11-04 09:01:58 ET https://markets-headlines.com/wp-content/uploads/2025/11/Precision-Biotech-Wave-Builds-As-FDA-Expedites-Breakthrough-Cell-And-Gene-Therapies.mp4 Issued on behalf of Avant Technologies Inc....

Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), a Nevada-based corporation, and SGAustria Pte. Ltd. (SGAustria), a Singapore-based biotechnology company, today announced the formation of a groundbreaking Joint Venture and License Agreement aimed at re...

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – Longevity science advances reveal how genes from supercentenarians can reverse cardiac aging [1] , while AI diagnostics platforms expand across U.S. healthcare system...

2025-10-21 09:21:30 ET https://markets-headlines.com/wp-content/uploads/2025/10/Beyond-Traditional-Drugs-Novel-Platforms-Targeting-Hard-to-Treat-Conditions.mp4 Equity Insider News Commentary Issued on be...

Avant Technologies and Austrianova Launch Klothonova, Begin Developing Age Related Cellular Therapies Using 'Longevity Protein' Klotho Canada NewsWire LAS VEGAS , Oct. 21, 2025 /CNW/ -- Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company") and global biotechnology ...